Ajooni Biotech Limited — Updates, 18-11-2024: Press Release

Ajooni Biotech has reported robust financial results for Q2 and H1 FY25, showcasing substantial growth. For Q2 FY25, the company achieved total income of ₹26.03 Cr, marking a year-on-year increase of 31.69%. EBITDA stood at ₹1.08 Cr, up 16.54%, with a margin of 4.15%. Net profit (PAT) reached ₹0.62 Cr, demonstrating impressive growth of 51.99%, resulting in a PAT margin of 2.39%. For H1 FY25, total income amounted to ₹51.73 Cr with a growth of 26.65%, while PAT surged to ₹1.28 Cr, reflecting a 58.59% year-on-year increase.

The company's entry into the high-margin B2C segment for pure vegetarian cattle feed in Gujarat positions it for enhanced profitability. Additionally, Ajooni has secured a significant order worth ₹4.95 Cr from a leading dairy supplier in Asia, showcasing strong demand for its offerings. The recent Bureau of Indian Standards (BIS) certification for its mineral mixture product further underscores Ajooni’s commitment to quality and could bolster its market reputation. Overall, the outlook remains positive, driven by strategic initiatives and market expansions.